UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____________________
FORM 8-K
_____________________
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of report (Date of earliest event reported): February 1, 2007
EXPRESS SCRIPTS, INC.
(Exact Name of Registrant as Specified in its Charter)
_____________________
|
DELAWARE (State or Other Jurisdiction of Incorporation) |
0-20199 (Commission File Number) |
43-1420563 (I.R.S. Employer Identification No.) |
|
13900 Riverport Drive (Address of Principal Executive Offices) |
|
63043 (Zip Code) |
|
Registrant’s telephone number including area code: (314) 770-1666 | ||
|
No change since last report (Former Name or Address, if Changed Since Last Report) | ||
_____________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
x Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01. Other Events.
On February 1, 2007, Express Scripts, Inc. (“Express Scripts”), issued a press release announcing that it had sent a letter to the stockholders of Caremark Rx, Inc. (“Caremark”). The press release, including the full text of the letter from Express Scripts to Caremark stockholders, is attached as Exhibit 99.1 to this Current Report and is incorporated herein by this reference.
Item 9.01. Financial Statements and Exhibits.
|
99.1 |
Express Scripts, Inc. press release, dated February 1, 2007. |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
EXPRESS SCRIPTS, INC | |
|
|
|
|
|
|
|
|
|
|
By: |
/s/ Thomas M. Boudreau |
|
|
Name: |
Thomas M. Boudreau |
|
|
Title: |
Senior Vice President and General |
|
|
|
Counsel |
Dated: February 1, 2007
Exhibit Index
|
Exhibit No. |
Exhibit
|
|
99.1 |
Express Scripts, Inc. press release, dated February 1, 2007. |